Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi cleared in sales row

September 20, 2012
Medical Communications, Sales and Marketing ABPI, CDF, Jevtana, PMCPA, Sanofi

Sanofi has been cleared of any wrongdoing after allegations that it had broken multiple clauses in the ABPI Code of …

News

Boehringer submits new lung cancer drug

September 20, 2012
Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib

Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …

News
peterson_600

Sandra Peterson joins J&J’s executive committee

September 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Sandra Peterson

Sandra Peterson will join Johnson & Johnson on 1 December as Group Worldwide chairman and member of the company’s executive …

Appointment
Afinitor image

Afinitor’s new UK indication launched

September 20, 2012
Sales and Marketing Afinitor, CHMP, Novartis, breast cancer

Novartis’ cancer drug Afinitor has been made available in the UK for patients with the most common form of advanced …

News

RSA announces new Board members

September 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nick Stephens, RSA executive search

Life sciences executive search and interim management specialists RSA has announced the appointment of Nick Stephens as executive chairman, John …

Appointment

Silence Therapeutics appoints chief medical adviser

September 19, 2012
Business Services, Research and Development, Sales and Marketing Michael Khan, Silence Therapeutics

Silence Therapeutics has announced the appointment of Michael Khan to its board of directors as chief medical adviser. Dr Khan …

Appointment
johnson and johnson image

J&J sets up life science centres

September 19, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation

Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …

News
steven_gillis

Steven Gillis to join Shire Board of directors

September 19, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Steven Gillis

Shire has announced that Dr Steven Gillis will join the Board of directors in October this year. On joining the …

Appointment
EMA building

Salmonson is new chair of CHMP

September 19, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, EMA, MPA, Salmonson

Dr Tomas Salmonson has been elected chair of the Committee for Medicinal Products for Human Use (CHMP) for a three-year …

News

Circassia appoints Stewart Sharpe as VP Commercial Operations

September 19, 2012
Medical Communications, Research and Development, Sales and Marketing Circassia, Stewart Sharpe

Speciality biopharma firm Circassia has announced the appointment of Stewart Sharpe to the newly-created position of vice president, Commercial Operations. …

Appointment
screen_shot_2012-09-18_at_15

Two new appointments at Pharmalink Consulting

September 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kevin Webb, Lorcan Flanagan, Pharmalink

Regulatory affairs specialists Pharmalink Consulting has announced two new appointments. Lorcan Flanagan (pictured) joins as European Business Development manager and …

Appointment
Boehringer image

Boehringer says it is rolling out ‘fully disposable’ biomanufacturing

September 18, 2012
Manufacturing and Production Boehringer, CMO, GMP, SUSs

Boehringer Ingelheim says it has developed a production platform for biopharmaceuticals that makes full use disposable technologies both upstream and …

News

API supply issues lead Lundbeck to drop cancer drug

September 18, 2012
Manufacturing and Production Elspar, Lundbeck, Ovation

Danish firm Lundbeck has decided to discontinue supplies of its leukaemia drug Elspar from December after struggling to find a …

News
Halaven image

UK at centre of Eisai plans

September 18, 2012
Research and Development, Sales and Marketing CNS, Cancer Drugs Fund, Eisai, Fycompa, Halaven

Diseases of the central nervous system (CNS) and cancer will be the main areas targeted by Japanese firm Eisai as …

News

Pfizer issues guide for medicines disposal

September 18, 2012
Manufacturing and Production EPA, PRDA, Pfizer

Pfizer has published a guide for the safe disposal of medicines targeted at healthcare professionals and facilities in the US. …

News
Mark Mallon image

Asia-Pacific – pharma’s new centre of gravity?

September 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia-Pacific, AstraZeneca

A high-growth region for the pharmaceutical industry, Asia-Pacific incorporates a vast geography with a $20 trillion economy, and is home …

Feature

New data for Pfizer arthritis pill

September 18, 2012
Research and Development, Sales and Marketing JAK, Pfizer, RA, tofacitinib

Pfizer is to release more data for its investigational rheumatoid arthritis (RA) pill tofacitinib which it hopes will demonstrate its …

News
john_evans_helix_health

Helix Health appoints John Evans as UK commercial manager

September 18, 2012
Medical Communications, Research and Development, Sales and Marketing Helix Health, John Evans

Healthcare IT provider Helix Health has recruited John Evans to the role of UK commercial manager to expand its UK …

Appointment

SHL to Exhibit at 2012 PDA Event in Las Vegas – Inspiring Integration

September 18, 2012
Manufacturing and Production auto injector, autoinjector, inspiring integration, pen injector, shl group

With the biopharmaceutical industry’s drug delivery landscape quickly adapting to the introduction of several biologics drugs in recent years, a …

News
Press release
Astrazeneca image

AstraZeneca signs MIT/Harvard research deal

September 17, 2012
Business Services, Research and Development, Sales and Marketing AstraZeneca, Deals, Havard, MIT

AstraZeneca has signed a two-year collaboration with an academic institution – affiliated to the illustrious universities MIT and Harvard – …

News
The Gateway to Local Adoption Series

Latest content

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026